Ocuphire Pharma
presbyopia phase design | Ocuphire Pharma
Company
Deck Type
Deck date
November 2021
Slide
6 of 13
Similar slides by Ocuphire Pharma
See diffirences between slides (animation)
Investor Day
January 2022
presbyopia phase trial design eaten | Ocuphire Pharma
Results
June 2021
presbyopia phase design | Ocuphire Pharma
Related slides by other companies
Matinas BioPharma
Investor Presentation
February 2024
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
Matinas BioPharma
Investor Presentation
March 2024
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
BioAtla
Investor Presentation
August 2023
phase study design with | BioAtla
MindMed
Investor Presentation
December 2024
phase trial of utilized standard gad design and and was aligned with draft guidance for drug class class | MindMed
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights